|
2019 Journal Article Exercise and sport science Australia position stand update on exercise and hypertensionSharman, James E., Smart, Neil A., Coombes, Jeff S. and Stowasser, Michael (2019). Exercise and sport science Australia position stand update on exercise and hypertension. Journal of Human Hypertension, 33 (12), 837-843. doi: 10.1038/s41371-019-0266-z |
|
2019 Journal Article Diagnosis of primary aldosteronism by seated saline suppression test - variability between immunoassay and HPLC-MS/MSThuzar, Moe, Young, Karen, Ahmed, Ashraf H., Ward, Greg, Wolley, Martin, Guo, Zeng, Gordon, Richard D., McWhinney, Brett C., Ungerer, Jacobus P. and Stowasser, Michael (2019). Diagnosis of primary aldosteronism by seated saline suppression test - variability between immunoassay and HPLC-MS/MS. Journal of Clinical Endocrinology and Metabolism, 105 (3) dgz150, e477-e483. doi: 10.1210/clinem/dgz150 |
|
2019 Journal Article Response to letter to the editor: "Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism"Stowasser, Michael, Guo, Zeng, Ahmed, Ashraf, Wolley, Martin and Gordon, Richard D. (2019). Response to letter to the editor: "Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism". The Journal of Clinical Endocrinology and Metabolism, 104 (6), 2344-2345. doi: 10.1210/jc.2019-00179 |
|
2019 Journal Article Pathogenesis of familial hyperaldosteronism type II: new concepts involving anion channelsStowasser, Michael, Wolley, Martin, Wu, Aihua, Gordon, Richard D., Schewe, Julia, Stoelting, Gabriel and Scholl, Ute I. (2019). Pathogenesis of familial hyperaldosteronism type II: new concepts involving anion channels. Current Hypertension Reports, 21 (4) 31, 31. doi: 10.1007/s11906-019-0934-y |
|
2019 Journal Article Mineralocorticoid antagonism enhances brown adipose tissue function in humans: a randomized placebo-controlled cross-over studyThuzar, Moe, Law, W. Phillip, Dimeski, Goce, Stowasser, Michael and Ho, Ken K. Y. (2019). Mineralocorticoid antagonism enhances brown adipose tissue function in humans: a randomized placebo-controlled cross-over study. Diabetes, Obesity and Metabolism, 21 (3), 509-516. doi: 10.1111/dom.13539 |
|
2019 Journal Article The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathwayWu, Aihua, Wolley, Martin and Stowasser, Michael (2019). The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway. Journal of Human Hypertension, 33 (7), 508-523. doi: 10.1038/s41371-019-0170-6 |
|
2019 Conference Publication The effect of rampiril on the aldosterone/renin ratio and aldosterone/andiotensin II ratio in patients with primary aldosteronism: a pilot studyGuo, Z., Cowley, D., Poglitsch, M., McWhinney, B., Ungerer, J., Wolley, M. and Stowasser, M. (2019). The effect of rampiril on the aldosterone/renin ratio and aldosterone/andiotensin II ratio in patients with primary aldosteronism: a pilot study. 29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH), Milan, Italy, 21-24 June 2019. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/01.hjh.0000570668.96581.d2 |
|
2019 Conference Publication Improving hypertension control by molecular stratification of first-line non-responders using RAAS triple-A testingPoglitsch, M., Ahmed, A. H., Guo, Z., Burrello, J., Stoller, A., Burkard, T., Domenig, O., Haschke, M., Mulatero, P. and Stowasser, M. (2019). Improving hypertension control by molecular stratification of first-line non-responders using RAAS triple-A testing. 29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH), Milan Italy, 21-24 June 2019. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/01.hjh.0000572980.98621.b4 |
|
2019 Conference Publication ACE-S: a novel angiotensin based marker for monitoring prarmacologic activity of ACE inhibitors in hypertensive patientsDomenig, O., Ahmed, A. H., Guo, Z., Stoller, A., Burkard, T., Haschke, M., Stowasser, M. and Poglitsch, M. (2019). ACE-S: a novel angiotensin based marker for monitoring prarmacologic activity of ACE inhibitors in hypertensive patients. 29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH), Milan, Italy, 21-24 June 2019. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/01.hjh.0000570640.20346.d4 |
|
2019 Conference Publication Defining the optimal cut-off plasma aldosterone level measured by immunoassay for the diagnosis of primary aldosteronism using seated salines suppression testThuzar, M., Young, K., Ahmed, A., Wolley, M., Guo, Z., Ward, G., McWhinney, B., Ungerer, J. and Stowasser, M. (2019). Defining the optimal cut-off plasma aldosterone level measured by immunoassay for the diagnosis of primary aldosteronism using seated salines suppression test. 29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH), Milan, Italy, 21-24 June 2019. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/01.hjh.0000570272.55373.54 |
|
2019 Book Chapter Primary aldosteronism; epidemiology and screeningStowasser, Michael (2019). Primary aldosteronism; epidemiology and screening. Encyclopedia of endocrine diseases. (pp. 598-606) edited by Ilpo Huhtaniemi and Luciano Martini. Amsterdam, Netherlands: Elsevier. doi: 10.1016/B978-0-12-801238-3.64331-3 |
|
2018 Journal Article Aldosterone LC-MS/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronismGuo, Zeng, Poglitsch, Marko, McWhinney, Brett C., Ungerer, Jacobus P. J., Ahmed, Ashraf H., Gordon, Richard D., Wolley, Martin and Stowasser, Michael (2018). Aldosterone LC-MS/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism. Journal of Clinical Endocrinology and Metabolism, 103 (11), 3965-3973. doi: 10.1210/jc.2018-01041 |
|
2018 Journal Article Cellular and genetic causes of idiopathic hyperaldosteronismOmata, Kei, Satoh, Fumitoshi, Morimoto, Ryo, Ito, Sadayoshi, Yamazaki, Yuto, Nakamura, Yasuhiro, Anand, Sharath K., Guo, Zeng, Stowasser, Michael, Sasano, Hironobu, Tomlins, Scott A. and Rainey, William E. (2018). Cellular and genetic causes of idiopathic hyperaldosteronism. Hypertension, 72 (4), 874-880. doi: 10.1161/HYPERTENSIONAHA.118.11086 |
|
2018 Journal Article Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronismStowasser, Michael, Ahmed, Ashraf H., Cowley, Diane, Wolley, Martin, Guo, Zeng, McWhinney, Brett C., Ungerer, Jacobus P. and Gordon, Richard D. (2018). Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism. The Journal of Clinical Endocrinology and Metabolism, 103 (11), 4113-4124. doi: 10.1210/jc.2018-01394 |
|
2018 Journal Article A young man with severe hypertensionTan, Jin Ern, Wu, Danielle and Stowasser, Michael (2018). A young man with severe hypertension. BMJ, 362 k2935, k2935. doi: 10.1136/bmj.k2935 |
|
2018 Journal Article Is it time to screen all patients with hypertension for primary aldosteronism?Yang, Jun, Fuller, Peter J. and Stowasser, Michael (2018). Is it time to screen all patients with hypertension for primary aldosteronism?. Medical Journal of Australia, 209 (2), 57-59. doi: 10.5694/mja17.00783 |
|
2018 Journal Article Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronismWilliams, Tracy A., Burrello, Jacopo, Sechi, Leonardo A., Fardella, Carlos E., Matrozova, Joanna, Adolf, Christian, Baudrand, René, Bernardi, Stella, Beuschlein, Felix, Catena, Cristiana, Doumas, Michalis, Fallo, Francesco, Giacchetti, Gilberta, Heinrich, Daniel A., Saint-Hilary, Gaëlle, Jansen, Pieter M., Januszewicz, Andrzej, Kocjan, Tomaz, Nishikawa, Tetsuo, Quinkler, Marcus, Satoh, Fumitoshi, Umakoshi, Hironobu, Widimský, Jiří, Hahner, Stefanie, Douma, Stella, Stowasser, Michael, Mulatero, Paolo and Reincke, Martin (2018). Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism. Hypertension, 72 (3), HYPERTENSIONAHA.118.11382-649. doi: 10.1161/HYPERTENSIONAHA.118.11382 |
|
2018 Conference Publication Effect of mineralocorticoid blockade on human brown fat-a randomised placebo-controlled cross-over studyThuzar, Moe, Law, W. Phillip, Dimeski, Goce, Stowasser, Michael and Ho, Ken K. Y. (2018). Effect of mineralocorticoid blockade on human brown fat-a randomised placebo-controlled cross-over study. Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), Perth Australia, Aug 27-30, 2017. HOBOKEN: WILEY. |
|
2018 Journal Article CLCN2 chloride channel mutations in familial hyperaldosteronism type IIScholl, Ute I., Stölting, Gabriel, Schewe, Julia, Thiel, Anne, Tan, Hua, Nelson-Williams, Carol, Vichot, Alfred A., Jin, Sheng Chih, Loring, Erin, Untiet, Verena, Yoo, Taekyeong, Choi, Jungmin, Xu, Shengxin, Wu, Aihua, Kirchner, Marieluise, Mertins, Philipp, Rump, Lars C., Onder, Ali Mirza, Gamble, Cory, McKenney, Daniel, Lash, Robert W., Jones, Deborah P., Chune, Gary, Gagliardi, Priscila, Choi, Murim, Gordon, Richard, Stowasser, Michael, Fahlke, Christoph and Lifton, Richard P. (2018). CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nature Genetics, 50 (3), 1-6. doi: 10.1038/s41588-018-0048-5 |
|
2017 Journal Article ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II)De Sousa, S. M. C., Stowasser, M., Feng, J., Schreiber, A. W., Wang, P., Hahn, C. N., Gordon, R. D., Torpy, D. J., Scott, H. S. and Gagliardi, L. (2017). ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II). Journal of Human Hypertension, 31 (12), 857-859. doi: 10.1038/jhh.2017.71 |
